Engineering self-assembled materials to study and direct immune function
dc.contributor.author | Tostanoski, L.H. | |
dc.contributor.author | Jewell, C.M. | |
dc.date.accessioned | 2019-07-15T16:17:01Z | |
dc.date.available | 2019-07-15T16:17:01Z | |
dc.date.issued | 2017 | |
dc.identifier.uri | https://www.scopus.com/inward/record.uri?eid=2-s2.0-85017430623&doi=10.1016%2fj.addr.2017.03.005&partnerID=40&md5=845a6376c51fb51dbbbac49360a207e5 | |
dc.identifier.uri | http://hdl.handle.net/10713/10061 | |
dc.description.abstract | The immune system is an awe-inspiring control structure that maintains a delicate and constantly changing balance between pro-immune functions that fight infection and cancer, regulatory or suppressive functions involved in immune tolerance, and homeostatic resting states. These activities are determined by integrating signals in space and time; thus, improving control over the densities, combinations, and durations with which immune signals are delivered is a central goal to better combat infectious disease, cancer, and autoimmunity. Self-assembly presents a unique opportunity to synthesize materials with well-defined compositions and controlled physical arrangement of molecular building blocks. This review highlights strategies exploiting these capabilities to improve the understanding of how precisely-displayed cues interact with immune cells and tissues. We present work centered on fundamental properties that regulate the nature and magnitude of immune response, highlight pre-clinical and clinical applications of self-assembled technologies in vaccines, cancer, and autoimmunity, and describe some of the key manufacturing and regulatory hurdles facing these areas. Copyright 2017 The Authors | en_US |
dc.description.sponsorship | This work was supported in part by the National Multiple Sclerosis Society Award # RG-1501-02968, the Damon Runyon Foundation # DRR3415, NSF CAREER Award # 1351688, Alex's Lemonade Stand # 27120, and the Juvenile Diabetes Research Foundation # 2-SRA-2016-319-S-B. L.H.T. is an NSF Graduate Fellow (# DGE1322106). | en_US |
dc.description.uri | https://www.doi.org/10.1016/j.addr.2017.03.005 | en_US |
dc.language.iso | en_US | en_US |
dc.publisher | Elsevier B.V. | en_US |
dc.relation.ispartof | Advanced Drug Delivery Reviews | |
dc.subject | Autoimmunity and tolerance | en_US |
dc.subject | Biomaterial | en_US |
dc.subject | Cancer | en_US |
dc.subject | Immunomodulation | en_US |
dc.subject | Manufacturing, regulatory approval and FDA | en_US |
dc.subject | Nanoparticle, microparticle, micelle, liposome, polyplex, lipoplex, polyelectrolyte multilayer | en_US |
dc.subject | Nanotechnology | en_US |
dc.subject | Non-covalent, hydrophobic, hydrogen bonding, and electrostatic interaction | en_US |
dc.subject | Self-assembly | en_US |
dc.subject | Sensor, diagnostic, and theranostic | en_US |
dc.subject | Vaccine and immunotherapy | en_US |
dc.title | Engineering self-assembled materials to study and direct immune function | en_US |
dc.type | Article | en_US |
dc.identifier.doi | 10.1016/j.addr.2017.03.005 | |
dc.identifier.pmid | 28392305 |